Dynamic Technology Lab Private Ltd acquired a new stake in Intrexon Corporation (NYSE:XON) in the 2nd quarter, according to the company in its most recent filing with the SEC. The fund acquired 10,857 shares of the biotechnology company’s stock, valued at approximately $262,000.

A number of other institutional investors and hedge funds have also modified their holdings of the business. Vanguard Group Inc. raised its position in Intrexon Corporation by 3.4% in the 2nd quarter. Vanguard Group Inc. now owns 4,433,879 shares of the biotechnology company’s stock valued at $106,811,000 after purchasing an additional 147,517 shares during the last quarter. State Street Corp raised its position in Intrexon Corporation by 34.0% in the 1st quarter. State Street Corp now owns 2,707,242 shares of the biotechnology company’s stock valued at $53,664,000 after purchasing an additional 687,406 shares during the last quarter. First Trust Advisors LP raised its position in Intrexon Corporation by 32.5% in the 2nd quarter. First Trust Advisors LP now owns 1,537,088 shares of the biotechnology company’s stock valued at $37,028,000 after purchasing an additional 376,780 shares during the last quarter. Geode Capital Management LLC raised its position in Intrexon Corporation by 3.5% in the 1st quarter. Geode Capital Management LLC now owns 429,532 shares of the biotechnology company’s stock valued at $8,513,000 after purchasing an additional 14,674 shares during the last quarter. Finally, Northern Trust Corp raised its position in Intrexon Corporation by 2.4% in the 2nd quarter. Northern Trust Corp now owns 322,110 shares of the biotechnology company’s stock valued at $7,760,000 after purchasing an additional 7,589 shares during the last quarter. Hedge funds and other institutional investors own 82.23% of the company’s stock.

Several equities analysts have issued reports on XON shares. Zacks Investment Research downgraded Intrexon Corporation from a “hold” rating to a “sell” rating in a research report on Monday, October 16th. Griffin Securities reiterated a “buy” rating and issued a $55.00 price objective on shares of Intrexon Corporation in a research report on Friday, October 6th. JMP Securities reiterated an “outperform” rating and issued a $42.00 price objective on shares of Intrexon Corporation in a research report on Thursday, October 5th. BidaskClub downgraded Intrexon Corporation from a “sell” rating to a “strong sell” rating in a research report on Tuesday, August 22nd. Finally, Northland Securities restated a “buy” rating and set a $27.00 target price on shares of Intrexon Corporation in a research report on Friday, October 6th. Two analysts have rated the stock with a sell rating, one has issued a hold rating and five have assigned a buy rating to the stock. The company has an average rating of “Hold” and an average target price of $43.20.

COPYRIGHT VIOLATION WARNING: This piece was originally posted by TheOlympiaReport and is the sole property of of TheOlympiaReport. If you are reading this piece on another website, it was illegally copied and reposted in violation of US & international copyright laws. The legal version of this piece can be read at https://theolympiareport.com/2017/10/31/dynamic-technology-lab-private-ltd-acquires-shares-of-10857-intrexon-corporation-xon.html.

In other news, CEO Randal J. Kirk purchased 132,625 shares of the company’s stock in a transaction dated Friday, August 11th. The stock was bought at an average cost of $18.85 per share, for a total transaction of $2,499,981.25. The purchase was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, Director Robert B. Shapiro purchased 2,850 shares of the company’s stock in a transaction dated Tuesday, August 22nd. The stock was purchased at an average price of $17.50 per share, with a total value of $49,875.00. Following the completion of the purchase, the director now directly owns 43,157 shares in the company, valued at approximately $755,247.50. The disclosure for this purchase can be found here. Insiders bought a total of 144,569 shares of company stock valued at $2,719,429 over the last quarter. 56.30% of the stock is owned by corporate insiders.

Shares of Intrexon Corporation (NYSE XON) opened at 16.58 on Tuesday. The company’s market cap is $2.00 billion. Intrexon Corporation has a 52-week low of $16.11 and a 52-week high of $32.90. The stock’s 50 day moving average price is $18.55 and its 200-day moving average price is $20.90.

Intrexon Corporation (NYSE:XON) last announced its quarterly earnings results on Wednesday, August 9th. The biotechnology company reported ($0.16) EPS for the quarter, beating the Zacks’ consensus estimate of ($0.21) by $0.05. Intrexon Corporation had a negative return on equity of 19.08% and a negative net margin of 60.63%. The company had revenue of $54.40 million during the quarter, compared to analysts’ expectations of $57.17 million. During the same period in the prior year, the company earned ($0.42) EPS. Intrexon Corporation’s revenue was up 3.6% compared to the same quarter last year. Equities analysts expect that Intrexon Corporation will post ($0.87) EPS for the current year.

About Intrexon Corporation

Intrexon Corporation (Intrexon) forms collaborations to create biologically-based products and processes using synthetic biology. The Company’s domestic operations are in California, Florida, Maryland, and Virginia, and its primary international operations are in Belgium and Hungary. The Company designs, builds and regulates gene programs, which are deoxyribonucleic acid (DNA) sequences that consist of genetic components.

Institutional Ownership by Quarter for Intrexon Corporation (NYSE:XON)

Receive News & Ratings for Intrexon Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intrexon Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.